Obesidad | 02 OCT 02
Obesidad y riesgo de insuficiencia cardíaca
Son pocos los datos que existen sobre la asociación de la insuficiencia cardíaca con el sobrepeso y grados menores de obesidad.
Autor/a: Dres. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ N Engl J Med 2002 Aug 1;347(5):305-13
Bibliografía
1. American Heart Association. 2002 Heart and stroke statistical update. Dallas: American Heart Association, 2001.
2. Junt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American Pcollege of Cardiolpy/American Heart Association Task Force on Practice guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001,38:2101-13.
3. Messerli FH, Sundgaard-Rüuse K, Reisin ED et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med 1983;99:757-61.
4. Hammond IW, Devereux RB, Alderman MH, Laragh IH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol 1988;12:996-1004.
5. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry; the Framingham Heart Shady. JAMA 1991,266:231-6.
6. Alpert MA, Lambert CR, Terry BE, et al. Influence of left ventricular mass on left ventricular diastolic filing in nonnotensive morbid obesity. Am Heart J 1995;130:1068-73.
7. Vasan KS, Larson MG, Banjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of connective heart failure in people without myocardial infarcfion. N Engl J Med 1997;336:1350-5.
8. Gardin IM, McClelland R, Kitznman D, et al. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study), Am J Cardioil 2001;87:l051-7.
9. Alpert MA. Obesisity, cardiomyopathy: pathophyiology and evolution of the clinical syndrome. Am J Med Sci 2001;321:225-36.
10. Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 1999;106:605-12.+
11. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women; NHANES I epidemiologic follow-up study. Arch Intern Med 2001;161:996-1002.
12. Wilhelmsen L, rosengren A, Eriksson H, Lappas G. Heart failure in the general population od men --morbidity, risk factors and prognosis. J Intern Med 2001;24~:255S-61.
13. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological appñroaches to heart disease the Framingham Study. Am J Public Health 1951;41 279-86.
14. Kannel WB, Feinleib M, McNamara PM, Garrison RL Castelli WP. Antiácido investiption of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 1979;,110:281-90.
15. Obesity: prventing and managing the global epidemic: report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:1-253.
16. Clinical guidelines on theidentification, evaluation, and treatment of overweight and obesity in adults. Bethesda, Md.: National Heart, Lung, and Blood Institute, 1998. (NIH publication no. 98-4083.)
17. Kannel WB, Wolf PA, Garrison RJ, eds. The Framinghan Study: an epidemiological ivesstigation of cardiovascular disease. Section 34. Some risk factors related to the annual incidence of cardiovascular disease and deahh us
2. Junt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American Pcollege of Cardiolpy/American Heart Association Task Force on Practice guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001,38:2101-13.
3. Messerli FH, Sundgaard-Rüuse K, Reisin ED et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med 1983;99:757-61.
4. Hammond IW, Devereux RB, Alderman MH, Laragh IH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol 1988;12:996-1004.
5. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry; the Framingham Heart Shady. JAMA 1991,266:231-6.
6. Alpert MA, Lambert CR, Terry BE, et al. Influence of left ventricular mass on left ventricular diastolic filing in nonnotensive morbid obesity. Am Heart J 1995;130:1068-73.
7. Vasan KS, Larson MG, Banjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of connective heart failure in people without myocardial infarcfion. N Engl J Med 1997;336:1350-5.
8. Gardin IM, McClelland R, Kitznman D, et al. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study), Am J Cardioil 2001;87:l051-7.
9. Alpert MA. Obesisity, cardiomyopathy: pathophyiology and evolution of the clinical syndrome. Am J Med Sci 2001;321:225-36.
10. Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 1999;106:605-12.+
11. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women; NHANES I epidemiologic follow-up study. Arch Intern Med 2001;161:996-1002.
12. Wilhelmsen L, rosengren A, Eriksson H, Lappas G. Heart failure in the general population od men --morbidity, risk factors and prognosis. J Intern Med 2001;24~:255S-61.
13. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological appñroaches to heart disease the Framingham Study. Am J Public Health 1951;41 279-86.
14. Kannel WB, Feinleib M, McNamara PM, Garrison RL Castelli WP. Antiácido investiption of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 1979;,110:281-90.
15. Obesity: prventing and managing the global epidemic: report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:1-253.
16. Clinical guidelines on theidentification, evaluation, and treatment of overweight and obesity in adults. Bethesda, Md.: National Heart, Lung, and Blood Institute, 1998. (NIH publication no. 98-4083.)
17. Kannel WB, Wolf PA, Garrison RJ, eds. The Framinghan Study: an epidemiological ivesstigation of cardiovascular disease. Section 34. Some risk factors related to the annual incidence of cardiovascular disease and deahh us
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024